QUINCE THERAPEUTICS INC (QNCX:NASDAQ)
$31.73 2.37 (8.0722%)
Analysed QUINCE THERAPEUTICS INC (QNCX:NASDAQ) News Sources
As Acasti Pharma Advances FDA Orphan-Designated GTX-102 Oral Mucosal Spray, New Report Maps 7MM Ataxia-Telangiectasia Treatment Landscape
14-08-2026
yahoo.com
Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD
18-05-2026
yahoo.com
Quince Announces Acquisition of Orphai and up to $187 Million Private Placement to Advance Pulmonary Pipeline
18-05-2026
yahoo.com
UPDATE - Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD
18-05-2026
yahoo.com
Quince Therapeutics Inc. (QNCX) Presents Positive Phase 2a Data for LAM-001 Inhaled Therapy
02-06-2026
yahoo.com
Quince Therapeutics Appoints Recognized Leaders in Pulmonary Medicine to Scientific Advisory Board
30-06-2026
yahoo.com
Quince Therapeutics to Participate in September 2026 Investor Conferences
03-09-2026
yahoo.com
Quince Therapeutics to Host Virtual KOL Event to Discuss the Current Treatment Landscape for PH-ILD and BOS and the Role for LAM-001 as a Potential Therapeutic Option on September 28, 2026
17-09-2026
yahoo.com
Quince Therapeutics Relaunches as IRulya Therapeutics with a Focus on the Clinical Development of LAM-001, Targeting a Key Pathway in Pulmonary Disease
09-10-2026
yahoo.com
Quince Therapeutics Renames as IRulya Therapeutics, Advances Pulmonary Drug Development
09-10-2026
advfn.com
What is the current price of QUINCE THERAPEUTICS INC (QNCX:NASDAQ)?
The current price of QUINCE THERAPEUTICS INC (QNCX:NASDAQ) is $31.73.
QUINCE THERAPEUTICS INC (QNCX:NASDAQ) absolute price change since previous trading day?
The absolute price change of QUINCE THERAPEUTICS INC (QNCX:NASDAQ) since the previous trading day is $2.37.
QUINCE THERAPEUTICS INC (QNCX:NASDAQ) percentage price change since previous trading day?
The percentage price change of QUINCE THERAPEUTICS INC (QNCX:NASDAQ) since the previous trading day is 8.0722%.
What is the most recent average sentiment score for QUINCE THERAPEUTICS INC (QNCX:NASDAQ)?
The most recent average sentiment score for QUINCE THERAPEUTICS INC (QNCX:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for QUINCE THERAPEUTICS INC (QNCX:NASDAQ)?
The most recent sentiment for QUINCE THERAPEUTICS INC (QNCX:NASDAQ) is .
SEC-8K** Filing Available For QUINCE THERAPEUTICS INC (QNCX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.